[Experience with a l-dopa retard preparation in the peroral long-term therapy of the Parkinsonian syndrome].
D000284:Administration, Oral; D000368:Aged; D000596:Amino Acids / Q000097:blood; D003692:Delayed-Action Preparations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D010302:Parkinson Disease, Secondary / Q000188:drug therapy*; D010552:Personality Assessment; D011569:Psychiatric Status Rating Scales
D000596:Amino Acids; D003692:Delayed-Action Preparations; D007980:Levodopa
Erfahrungen mit einem L-Dopa-Retard-Präparat in der peroralen Langzeittherapie des Parkinson-Syndroms